Swiss Personal Products Stock News

Earlier this month, Genentech, a member of the Roche Group, received U.S. FDA accelerated approval for Lunsumio VELO, a subcutaneous formulation of mosunetuzumab for adults with relapsed or refractory follicular lymphoma after at least two prior systemic therapies, cutting administration time from hours to about one minute. This approval not only broadens Roche’s oncology offering but also highlights how treatment convenience and clinic efficiency are becoming core differentiators in cancer...

ABB (SWX:ABBN) just landed a new contract with the Canadian Space Agency to design the ALExIS infrared spectrometer for Canada’s upcoming lunar rover, putting its space instrumentation credentials firmly in the spotlight for investors. See our latest analysis for ABB. The ALExIS win comes on top of a solid run, with ABB’s share price up meaningfully this year and a strong multi year total shareholder return suggesting momentum is still building rather than fading. If this space contract has...

As European markets experience a boost from steady economic growth and looser monetary policy, the pan-European STOXX Europe 600 Index has ended the week 1.60% higher, with major stock indexes also showing gains. In this environment of cautious optimism, dividend stocks can offer investors a reliable income stream and potential for capital appreciation, making them an attractive option in today's market conditions.

While Medartis Holding AG ( VTX:MED ) might not have the largest market cap around , it led the SWX gainers with a...

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...

Implenia AG ( VTX:IMPN ) shareholders would be excited to see that the share price has had a great month, posting a 25...

By buying an index fund, investors can approximate the average market return. But if you pick the right individual...

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...

Despite an already strong run, Bellevue Group AG ( VTX:BBN ) shares have been powering on, with a gain of 27% in the...

Key Insights Bucher Industries' significant retail investors ownership suggests that the key decisions are influenced...

Alcon (SWX:ALC) has quietly outperformed the broader healthcare space over the past month, with shares climbing about 4% even as the stock remains down sharply year to date. See our latest analysis for Alcon. That recent 30 day share price return of 3.84% looks more like a stabilisation than a full reversal. The year to date share price is still down 16.42%, and the one year total shareholder return is negative but modestly positive over three years. If Alcon’s move has you reassessing the...

Swissquote Group Holding SA's ( VTX:SQN ) price-to-earnings (or "P/E") ratio of 23.6x might make it look like a sell...

Clariant (SWX:CLN) has been grinding through a tricky stretch, with the share price down sharply this year even as revenue and net income inch higher. That disconnect is what matters for investors now. See our latest analysis for Clariant. With the share price now around CHF 7.12, a steep year to date share price loss contrasts with modest revenue and earnings growth. This suggests sentiment is still catching up to fundamentals and that momentum remains fragile rather than firmly...

Lonza Group AG ( VTX:LONN ) saw significant share price movement during recent months on the SWX, rising to highs of...

Idorsia Ltd ( VTX:IDIA ) shares have had a really impressive month, gaining 28% after a shaky period beforehand. The...

With a price-to-earnings (or "P/E") ratio of 37.5x Barry Callebaut AG ( VTX:BARN ) may be sending very bearish signals...

The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even...

With its stock down 7.7% over the past month, it is easy to disregard Adecco Group (VTX:ADEN). Given that stock prices...

If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...

UBS Group AG recently outlined further Credit Suisse integration steps, including multi-wave job cuts through 2026 and leadership changes in operations and technology, with Group Technology set to report to incoming Group Chief Operating Officer Beatriz Martin from January 2026. By consolidating technology under the Group COO and emphasizing artificial intelligence and IT migration, UBS is signaling a push to streamline operations while completing the complex Credit Suisse integration. We’ll...

When you buy shares in a company, it's worth keeping in mind the possibility that it could fail, and you could lose...

Key Insights Using the 2 Stage Free Cash Flow to Equity, Huber+Suhner fair value estimate is CHF109 Current share price...

Key Insights The projected fair value for Amrize is CHF82.29 based on 2 Stage Free Cash Flow to Equity Current share...

Many investors define successful investing as beating the market average over the long term. But if you try your hand...